Welcome to Cyberonics
Cyberonics, Inc. (NASDAQ: CYBX) pioneered the Vagus Nerve Stimulation (VNS Therapy®) System. Founded in 1987 to design, develop and market implantable medical devices for the treatment of epilepsy and other debilitating neurological disorders, Cyberonics has emerged as a leader in the neuromodulation industry.
The remarkable success of VNS Therapy in the treatment of epilepsy has served as a platform for continued innovation. On July 15, 2005, after seven years of extensive study and clinical trials, VNS Therapy was approved by the FDA as a long-term adjunctive treatment for treatment-resistant depression. It is also at various levels of study as a potential treatment for other chronic disorders, including anxiety, Alzheimer’s, bulimia, and migraine headaches.
Cyberonics is committed to advancing the treatment of epilepsy through new technologies.
Headquartered in Houston, Texas, Cyberonics also has an office in Brussels, Belgium. The company markets the VNS Therapy system in more than 70 countries worldwide.
